Drugmakers seek incentives to develop antibiotics to fight 'superbugs'
They also call for diagnostic tests so that antibacterial drugs are not used needlessly
Add BT as a preferred source
New York
MORE than 80 pharmaceutical and diagnostic companies from around the world are calling for new economic models to spur development of badly needed new antibiotics and to fight the rising global threat of drug-resistant "superbugs."
In a declaration that is being released on Thursday at the World Economic Forum in Davos, Switzerland, the companies say that governments must work with companies to fight the problem of antimicrobial resistance, in which many germs are no longer killed by common antibiotics and in some cases even by last-ditch options, turning once-treatable infections into life-threatening events.
Share with us your feedback on BT's products and services
